TomoTherapy Earns Top Honors in MD Buyline Review of Radiation
Therapy Vendors
MADISON, Wis. (Business Wire EON/PRWEB ) May 28, 2008 --
TomoTherapy Incorporated
(NASDAQ: TOMO) today announced that it has earned the top user
satisfaction composite rating among four vendors in the linear
accelerator-based radiation therapy marketplace. The ratings appear in
MD Buyline's Quarterly User Satisfaction Report, which was published on
April 15, 2008.
MD Buyline, a leading independent healthcare research company, measures
user satisfaction by surveying each vendor’s
installed base. Hospitals and cancer centers rank their satisfaction in
six areas: system performance; system reliability; installation and
implementation; applications training; service response time; and
service repair quality.
In MD Buyline-conducted user interviews, customers noted the TomoTherapy®
Hi·Art®
treatment system’s strengths as its unique
design and software, and superiority for intensity-modulated radiation
therapy (IMRT). With respect to the company, customers noted: an
improvement in overall system reliability; satisfaction with how
manufacturer pre-sets and commissioning shorten the installation
process; and greater satisfaction in system service.
In rating TomoTherapy, MD Buyline wrote, “TomoTherapy
is the only vendor for the CT-based linear accelerator which delivers
radiation dose in a helical or fan beam fashion. Elekta, Siemens and
Varian offer IMRT and IGRT options on conventional linear accelerator
systems.”
Said Fred Robertson, CEO of TomoTherapy: “Our
customers expect the best from TomoTherapy because we are the industry
innovator and treatment quality leader. The MD Buyline surveys, a
resource for more than 3,300 hospitals, indicate that we are meeting
expectations. Of course, we know there is more work to be done. On
behalf of our customers and their patients, we are committed to
continually improving our revolutionary radiation therapy platform."
MD Buyline is a market intelligence organization founded in 1983. It
provides the healthcare industry with independent analysis and reporting.
About TomoTherapy Incorporated
TomoTherapy Incorporated has developed, markets and sells the TomoTherapy®
Hi·Art®
treatment system, an advanced radiation therapy system for the treatment
of a wide variety of cancers. The Hi·Art
treatment system combines integrated CT imaging with conformal radiation
therapy to deliver sophisticated radiation treatments with speed and
precision while reducing radiation exposure to surrounding healthy
tissue. The company’s stock is traded on the
NASDAQ Global Select Market under the symbol TOMO. To learn more about
TomoTherapy, please visit TomoTherapy.com.
See the original story at: http://eon.businesswire.com/releases/tomotherapy/md_buyline/prweb978294.htm
Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/SW5zZS1NYWduLUZhbHUtQ3Jhcy1DcmFzLVplcm8=
Bookmark -
Del.icio.us |
Furl It |
Technorati |
Ask |
MyWeb |
Propeller |
Live Bookmarks |
Newsvine |
TailRank |
Reddit |
Slashdot |
Digg |
Stumbleupon |
Google Bookmarks |
Sphere |
Blink It |
Spurl
|
